Search for: "Mylan Pharmaceuticals"
Results 721 - 739
of 739
Sort by Relevance
|
Sort by Date
15 Jun 2007, 8:11 am
Mylan Laboratories, Inc., et al., and Ormco Corporation, et al. v. [read post]
26 May 2007, 11:26 pm
Seasonale had about $35 million in annual sales last year.# Johnson & Johnson's epilepsy drug Topamax, which had $2 billion in 2006 sales, is being challenged by Mylan Laboratories. [read post]
21 May 2007, 3:26 pm
Mylan lost that case and appealed to the D.C. [read post]
3 May 2007, 12:07 pm
Read Cal Crary's full analysis of the impact of KSR on pharmaceutical litigation: Download litno337ksr.pdf [read post]
30 Apr 2007, 8:18 am
Mylan, in which the Federal Circuit invalidated Alza's patent on an extended-release formulation of Ditropan. [read post]
5 Apr 2007, 5:39 am
Von Eschenbach, 459 F.3d 1033, 1043 (10th Cir. 2006); Mylan Pharmaceuticals, Inc. v. [read post]
25 Mar 2007, 9:46 pm
The CAFC got into the matter than Berge disclosed 53 pharmaceutically-acceptable anions. [read post]
23 Mar 2007, 1:07 am
She ordered Mylan to pay $11.4 million in fees and Alphapharm to pay $5.4 million. [read post]
22 Mar 2007, 9:57 pm
In the Federal Circuit opinion released today, a unanimous three-judge panel determined that claims 1-3 of the '353 patent, directed to amlodipine besylate and pharmaceutical and tablet formulations thereof, are invalid as obvious. [read post]
22 Mar 2007, 1:18 pm
But, Pfizer won in three earlier district court cases, including a case against Mylan Pharmaceuticals that was handed down just last month. [read post]
14 Mar 2007, 3:15 pm
It will also feature faculty from Eli Lilly, Forest Laboratories, Mayne Pharma, Merck, Mylan, Pfizer, Purdue Pharma, Upsher-Smith, and Wyeth. [read post]
15 Feb 2007, 8:26 am
The '006 patent covers the drug topiramate, pharmaceutical compositions containing topiramate, and a method of using topiramate to treat convulsions. [read post]
14 Feb 2007, 9:33 pm
Ruling in favor of Johnson & Johnson over Mylan concerning the patent US 4,513,006 on Topamax in February 2007, Judge Stanley Chesler found Mylan's arguments unpersuasive and noted the generic drugmaker "has not presented even a theory of obviousness. [read post]
25 Jan 2007, 12:48 am
Friedlander, 103 F.3d 1105, 1113 (2d Cir. 1997); Mylan Laboratories, Inc. v. [read post]
5 Nov 2006, 8:29 pm
KV Pharmaceutical Uniretic--Schwarz Pharma v. [read post]
27 Oct 2006, 9:43 am
In Ortho-McNeil Pharmaceutical v. [read post]
7 Sep 2006, 3:46 pm
Mylan Laboratories, Inc., et al. [read post]
8 Mar 2006, 5:12 am
Mylan Pharmaceuticals, Inc. v. [read post]
21 Feb 2006, 10:13 pm
The consolidated defendants (Mylan Laboratories Inc, Mylan Pharmaceuticals, Inc., UDL Laboratories, Inc., Alphapharm Pty. [read post]
